Kinch MS - Search Results

1

PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, Cheng L. Pan CX, et al. Among authors: kinch ms. Clin Cancer Res. 2004 Feb 15;10(4):1333-7. doi: 10.1158/1078-0432.ccr-1123-03. Clin Cancer Res. 2004. PMID: 14977833

2

High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.

Zeng G, Hu Z, Kinch MS, Pan CX, Flockhart DA, Kao C, Gardner TA, Zhang S, Li L, Baldridge LA, Koch MO, Ulbright TM, Eble JN, Cheng L. Zeng G, et al. Among authors: kinch ms. Am J Pathol. 2003 Dec;163(6):2271-6. doi: 10.1016/S0002-9440(10)63584-5. Am J Pathol. 2003. PMID: 14633601 Free PMC article.

3

Loss of 14-3-3sigma in prostate cancer and its precursors.

Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM, Eble JN. Cheng L, et al. Among authors: kinch ms. Clin Cancer Res. 2004 May 1;10(9):3064-8. doi: 10.1158/1078-0432.ccr-03-0652. Clin Cancer Res. 2004. PMID: 15131044

4

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Among authors: kinch ms. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

5

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.

Abraham S, Knapp DW, Cheng L, Snyder PW, Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J, Mohammed SI. Abraham S, et al. Clin Cancer Res. 2006 Jan 15;12(2):353-60. doi: 10.1158/1078-0432.CCR-05-1505. Clin Cancer Res. 2006. PMID: 16428472

6

Differential EphA2 epitope display on normal versus malignant cells.

Coffman KT, Hu M, Carles-Kinch K, Tice D, Donacki N, Munyon K, Kifle G, Woods R, Langermann S, Kiener PA, Kinch MS. Coffman KT, et al. Among authors: kinch ms. Cancer Res. 2003 Nov 15;63(22):7907-12. Cancer Res. 2003. PMID: 14633720

7

Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.

Hammond SA, Lutterbuese R, Roff S, Lutterbuese P, Schlereth B, Bruckheimer E, Kinch MS, Coats S, Baeuerle PA, Kufer P, Kiener PA. Hammond SA, et al. Among authors: kinch ms. Cancer Res. 2007 Apr 15;67(8):3927-35. doi: 10.1158/0008-5472.CAN-06-2760. Cancer Res. 2007. PMID: 17440108

8

A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

Jackson D, Gooya J, Mao S, Kinneer K, Xu L, Camara M, Fazenbaker C, Fleming R, Swamynathan S, Meyer D, Senter PD, Gao C, Wu H, Kinch M, Coats S, Kiener PA, Tice DA. Jackson D, et al. Cancer Res. 2008 Nov 15;68(22):9367-74. doi: 10.1158/0008-5472.CAN-08-1933. Cancer Res. 2008. PMID: 19010911

9

EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.

Lu M, Miller KD, Gokmen-Polar Y, Jeng MH, Kinch MS. Lu M, et al. Among authors: kinch ms. Cancer Res. 2003 Jun 15;63(12):3425-9. Cancer Res. 2003. PMID: 12810680

10

Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.

Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, Walsh B, Mao SY, Gao C, Kiener PA, Coats S, Kinch MS, Tice DA. Mulgrew K, et al. Among authors: kinch ms. Mol Cancer Ther. 2006 Dec;5(12):3122-9. doi: 10.1158/1535-7163.MCT-06-0356. Mol Cancer Ther. 2006. PMID: 17172415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters